secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001104659-25-028821
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics stockholders approve issuance of 8.28M warrant shares
-------------------------------------------------------------------------

- At special meeting on March 21, 2025, 4,158,543 shares (38.83% of outstanding) represented.
- Proposal passed: 3,483,897 for, 668,383 against, 6,263 abstained.
- Approves issuance of up to 5,031,250 shares under Series A Warrants and 3,247,445 under Series B Warrants.
- Total authorized warrant shares: 8,278,695, approximately 77% of 10.7M outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/0001104659-25-028821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/tm2510592d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-028821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer